Medication info

MultiHance Injection Prefilled Syringe (Gadobenate Dimeglumine)

Prescription medicationInjection
Ingredient · strength
Detapenta›0.2567gGadolinium Oxide›0.0918g
Manufacturer / importer
Bracco Imaging Korea
Appearance
A colorless and transparent injection solution filled in a prefilled syringe.
Packaging
10 mL / Prefilled Syringe [x1], 15 mL / Prefilled Syringe [x1], 20 mL / Prefilled Syringe [x1]
Approval status
Active

MFDS item code 201104130 · Approved 2011.06.29 · Insurance code 621400191

Summary

Main use
Improvement of diagnostic imaging of liver lesions using magnetic resonance imaging contrast
Who receives it
Adults
Adult administration
This medicine is administered by intravenous bolus injection or slow intravenous infusion (10 mL/min) in the following case. 1. Liver diagnosis: 0.1 mL/kg (0.05 mmol/kg) The liver shows an immediate contrast effect when administered as a bolus injection (dynamic MRI). For delayed MRI of the liver, diagnostic images can be obtained between 40-120 minutes, as required for diagnosis.

Ingredients

Importer
Bracco Imaging Korea

Efficacy & effects

Improvement of diagnostic imaging of liver lesions using magnetic resonance imaging contrast

View approved original text

This medication helps to observe the liver more accurately during magnetic resonance imaging (MRI) diagnosis. It is particularly used to diagnose liver lesions when primary liver cancer such as hepatocellular carcinoma or cancer metastatic to the liver from other sites is suspected. This helps to clarify the location and condition of liver diseases, facilitating the establishment of appropriate treatment plans. Liver contrast agents play an essential role in enhancing the accuracy of diagnoses and are crucial for patient healthcare.

How it is given

Adult administration

This medicine is administered by intravenous bolus injection or slow intravenous infusion (10 mL/min) in the following case. 1. Liver diagnosis: 0.1 mL/kg (0.05 mmol/kg) The liver shows an immediate contrast effect when administered as a bolus injection (dynamic MRI). For delayed MRI of the liver, diagnostic images can be obtained between 40-120 minutes, as required for diagnosis.

Precautions

This drug may pose a risk of serious side effects, such as nephrogenic systemic fibrosis, when administered to patients with severe kidney dysfunction, thus kidney function must be confirmed. This drug is not approved for intrathecal administration, and serious side effects may occur with such use, therefore it must not be used. When administered multiple times, gadolinium may accumulate in the brain, so careful consideration is necessary when administration is required. Patients with a history of allergic reactions to this drug's ingredients or gadolinium allergy, pregnant women, and patients with severely impaired renal function should not be administered this drug. Particular caution should be exercised with patients under 18 years of age or those with cardiovascular diseases, and careful usage is advised in cases of allergy history or specific heart conditions. After administration, monitoring for adverse reactions is required for at least 15 minutes under a doctor's observation, and it must only be used at medical facilities prepared for emergencies. The effects of this drug on driving or machine operation are unknown; caution is advised during use. Pregnant women should avoid use of this drug, and if breastfeeding, temporary cessation of breastfeeding around the time of administration is recommended. Elderly patients have an increased possibility of decreased kidney function and should be cautious regarding dose adjustments and intervals. No specific symptoms have been reported with overdose, but the prescribed dosage should not be exceeded, and patients should be closely monitored in case of overdose. This drug should be used immediately after opening and must not be diluted or mixed with other drugs. To prevent extravasation from intravenous injection, it should be administered accurately, and saline should be used for flushing after administration. It must not be frozen during storage, and discoloration or foreign substances must be checked before use.

Side effects

Burning sensation, itching, red or dark spots, skin swelling, hardening, rigidity, yellow spots in the sclera, joint rigidity, movement disorders of the arms, hands, legs, and feet, deep pain in the pelvic bones or ribs, muscle weakness, nasopharyngitis, headache, sensory disturbances, dizziness, fainting, olfactory disturbances, tremors, hypersensitivity, increased intracranial pressure, hemiplegia, conjunctivitis, tinnitus, palpitations, atrial fibrillation, first-degree atrioventricular block, ventricular premature contractions, bradycardia, tachycardia, arrhythmia, myocardial ischemia, prolonged PR interval, vasodilation, hypertension, hypotension, rhinitis, idiopathic respiratory distress, laryngospasm, wheezing, pulmonary congestion, pulmonary edema, nausea, dry mouth, taste disturbances, diarrhea, vomiting, dyspepsia, salivation, abdominal pain, constipation, fecal incontinence, necrotizing pancreatitis, itching sensations, rash, facial swelling, urticaria, sweating, low back pain, myalgia, urinary incontinence, urgency, injection site reactions, heat sensation, weakness, fever, chills, chest pain, pain, injection site pain, injection site leakage, injection site inflammation, abnormal clinical test results, abnormal electrocardiogram, increased QT interval, hypopigmented anemia, leukocytosis, leukopenia, eosinophilia, hypoalbuminemia, hypocalcemia, hyperkalemia, hyperglycemia, hypoglycemia, proteinuria, diabetes, hematuria, hyperlipidemia, hyperbilirubinemia, increased serum iron, elevated serum transaminase, increased alkaline phosphatase, elevated lactate dehydrogenase, increased serum creatinine, left or right bundle branch block, increased heart rate, auditory disturbances, decreased vision, limb artery embolism, bronchitis, tongue swelling, hematoma, chest pain, scleroderma, allergic dermatitis, fatigue, muscle cramps, muscular spasms, limb pain, drowsiness, migraine, hematuria, decreased renal function, urethral infection, dehydration, elevated liver enzymes, increased monocytes, increased red blood cells, increased platelet count, increased γ-glutamyl transferase, increased neutrophils, decreased hematocrit, reduced hemoglobin, increased lymphocytes, increased urine specific gravity, heart murmurs, pulmonary rales, hypersensitivity reactions including anaphylactic shock, pseudoanaphylactic reactions, angioedema, laryngeal spasm, rash, localized pain, burning sensation, swelling, blister formation, cardiac arrest, hypotension, nausea, vomiting, warmth sensation, itching, skin rash, cold sensation, pressure sensation, dizziness, pain, abdominal pain, diarrhea, symptoms resembling pseudoanaphylaxis, chest pain, urticaria, tremors, general anesthesia symptoms, cough, respiratory distress, respiratory anxiety, laryngospasm, myalgia, urinary incontinence

Not everyone experiences these, and they can vary from person to person.

Storage

This drug must be stored in a sealed container to prevent contact with air. The suitable storage temperature is between 1 and 25 degrees Celsius, and extremes of heat or cold should be avoided.

Appearance and packaging

Appearance

A colorless and transparent injection solution filled in a prefilled syringe.

Package unit

10 mL / Prefilled Syringe [x1], 15 mL / Prefilled Syringe [x1], 20 mL / Prefilled Syringe [x1]

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.